We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.
HomeHormone TherapyEstrogen PatchesTexasHouston
Houston, Texas · Telehealth Available

Estrogen Patches Online for Women in Houston, Texas

Estrogen patches deliver consistent, controlled estradiol through the skin — one of the most effective and well-studied forms of hormone replacement therapy for menopause and perimenopause symptoms. Available to women in Houston and across Texas's varied climate from humid Gulf coast to arid west — entirely online.

Start Your Free Intake →

Licensed in Texas · Ships to Houston in 3–5 business days · Reviewed within 24 hours

Is Estrogen Patches right for you?

Connect with a kindr-licensed provider who can evaluate whether Estrogen Patches is appropriate for your health history — from anywhere in the Houston area.

  • Hot flashes and night sweats
  • Sleep disruption and insomnia
  • Mood changes and anxiety
  • Brain fog and difficulty concentrating
  • Joint pain and fatigue

What is estrogen patches?

An estrogen patch is a small, thin adhesive worn on the skin — typically the lower abdomen or upper hip — that releases estradiol (the same estrogen your ovaries produced before menopause) directly into the bloodstream at a steady, controlled rate. Patches are changed once or twice weekly depending on the formulation.

The most common doses range from 0.025 mg/day to 0.1 mg/day. Transdermal delivery bypasses the liver, which is why menopause specialists frequently prefer patches over oral estrogen for women with cardiovascular risk factors, migraine, high triglycerides, or a history of gallbladder disease.

How estrogen patches works

Estradiol from the patch binds to estrogen receptors throughout the body — brain, blood vessels, bone, skin, urogenital tissue, and connective tissue. Restoring physiologic estrogen levels stabilizes the hypothalamic thermoregulatory set point (reducing hot flashes), supports serotonin and GABA signaling (improving mood and sleep), and preserves bone mineral density.

Because transdermal estradiol avoids first-pass hepatic metabolism, it does not raise clotting factors the way oral estrogen can. Large observational studies (including a 2019 BMJ analysis of over 80,000 women) show no increased risk of venous thromboembolism with transdermal estrogen at standard doses.

The clinical evidence

The North American Menopause Society (NAMS) 2022 Position Statement identifies transdermal estradiol as a first-line hormone therapy for symptomatic women within 10 years of menopause onset or under age 60. The KEEPS and ELITE randomized trials both used transdermal estradiol and demonstrated symptom relief, cardiovascular safety, and preservation of bone density in appropriately selected women.

A 2017 Cochrane review of 24 randomized trials concluded that transdermal estradiol reduces hot flash frequency by 75-90% compared with placebo, with a favorable safety profile in women without absolute contraindications.

Who is a good candidate?

  • Women in perimenopause or menopause with moderate to severe vasomotor symptoms
  • Women within 10 years of their last menstrual period, or under age 60
  • Women with elevated triglycerides, migraine with aura, or cardiovascular risk factors that make oral estrogen less ideal
  • Women who prefer steady-state hormone delivery to daily oral dosing
  • Women with an intact uterus (combined with progesterone) or after hysterectomy (estrogen alone)

Contraindications

  • Personal history of estrogen-sensitive breast cancer or endometrial cancer
  • Active or recent venous thromboembolism, stroke, or coronary event
  • Undiagnosed abnormal uterine bleeding
  • Active liver disease
  • Known or suspected pregnancy
  • Known hypersensitivity to estradiol or patch adhesive components

Common side effects

Most side effects are mild and settle within the first 4-8 weeks. Report anything severe or persistent to your prescriber.

  • Skin irritation at the patch site (usually mild and rotates with placement)
  • Breast tenderness during the first 4-8 weeks
  • Nausea (uncommon with transdermal)
  • Headache during dose adjustment
  • Breakthrough bleeding, especially in the first 3-6 months

How kindr delivers care in Houston

Step 1

Complete your intake online from Houston

Step 2

A Texas-licensed provider reviews within 24 hours

Step 3

If prescribed, ships free to Houston

A kindr physician reviews your health history and symptoms. If an estrogen patch is clinically appropriate, a prescription is sent to an FDA-registered compounding pharmacy and shipped free to your door.

What to expect

  • Weeks 1-2
    Sleep quality often improves first; night sweats begin to reduce
  • Weeks 4-6
    Meaningful reduction in hot flash frequency and intensity
  • Weeks 8-12
    Stabilization of mood, energy, and cognitive symptoms
  • Months 6-12
    Full protocol effect; bone density preservation established

In 2025, the FDA updated its guidance on hormone therapy for menopause, removing longstanding warnings that had deterred many women from effective treatment. Speak with a kindr provider about what this means for you.

Clinical standards — every time

Board-certified MDs and DOs licensed in Texas
FDA-registered 503A pharmacy fulfillment
HIPAA compliant and SOC 2 certified
LegitScript certified telehealth

Houston frequently asked questions

Alternatives to consider

Estradiol cream or gel
Also transdermal, dose-flexible; requires daily application
Oral estradiol
Simpler dosing but hepatic first-pass; less ideal with cardiovascular risk
Combination patches
Estrogen + progestin in one patch, for women with an intact uterus
Non-hormonal options
Paroxetine or desvenlafaxine for women who cannot use estrogen

Sources

  1. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
  2. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: BMJ 2019;364:k4810.
  3. Marjoribanks J, Farquhar C, Roberts H, et al. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017.
  4. Harman SM et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: KEEPS trial. Ann Intern Med. 2014;161:249-260.
  5. Hodis HN et al. Vascular effects of early versus late postmenopausal treatment with estradiol: ELITE trial. N Engl J Med. 2016;374:1221-1231.

Medically reviewed by the kindr Clinical Team. Content reflects the 2022 NAMS Position Statement and current Endocrine Society guidelines. Last reviewed 2026.

Nearby cities

San AntonioDallasAustinFort Worth

Ready to speak with a licensed provider?

Connect with a board-certified kindr physician licensed in Texas. No waiting rooms. No referrals. Reviewed within 24 hours.

Start Your Free Intake →

Estrogen Patches is a prescription medication. A licensed provider must evaluate whether this treatment is right for you. kindr is not a pharmacy. Medications are prescribed by licensed independent physicians and fulfilled by FDA-registered 503A compounding pharmacies. kindr does not guarantee any specific treatment will be prescribed.

Ask Dot